Lv21
180 积分 2024-08-22 加入
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
12天前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
12天前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
16天前
已完结
Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend Analysis
24天前
已完结
Time-Dependent Inhibition of CYP1A2 by Stiripentol and Structurally Related Methylenedioxyphenyl Compounds via Metabolic Intermediate Complex Formation
25天前
已完结
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies
26天前
已完结
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
1个月前
已完结
Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes
1个月前
已完结
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9
1个月前
已完结
Amylin receptor subunit interactions are modulated by agonists and determine signaling
1个月前
已完结
皖公网安备34019202002308
